Kush Parmar

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Kush Parmar
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kush Parmar:

Company Role Class Num Shares Value Price $ Report Date Ownership
Entrada Therapeutics, Inc. Director, 10%+ Owner Common Stock 2,963,066 $26,074,980 $8.80 14 Nov 2025 By 5AM Ventures V, L.P.
Entrada Therapeutics, Inc. Director, 10%+ Owner Common Stock 1,093,313 $6,756,674 $6.18 14 Nov 2025 By 5AM Opportunities I, L.P.
Homology Medicines, Inc. Director Option (Right to Buy) 18,000 $241,560 $13.42 15 Jun 2022 Direct
Rallybio Corp Director Option (Right to Buy) 16,500 $29,205 $1.77 15 May 2024 Direct
Entrada Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 19,000 11 Jun 2025 Direct
Vor Biopharma Inc. Director, 10%+ Owner Stock Option (right to buy) 16,911 14 Jun 2022 Direct
Akouos, Inc. Director, 10%+ Owner Common Stock 0 $12.50 30 Nov 2022 Indirect
Akouos, Inc. Director, 10%+ Owner Stock Option (right to buy) 0 01 Dec 2022 Direct

Insider Reports Filed by Kush Parmar

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRDA Entrada Therapeutics, Inc. 14 Nov 2025 1 -$1,760,000 4 Director, 10%+ Owner 18 Nov 2025, 16:36
TRDA Entrada Therapeutics, Inc. 09 Jul 2025 2 -$202,554 4 Director, 10%+ Owner 11 Jul 2025, 17:27
TRDA Entrada Therapeutics, Inc. 27 Jun 2025 6 -$866,632 4 Director, 10%+ Owner 01 Jul 2025, 20:33
TRDA Entrada Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director, 10%+ Owner 12 Jun 2025, 08:10
TRDA Entrada Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director, 10%+ Owner 14 Jun 2024, 16:39
RLYB Rallybio Corp 15 May 2024 1 $0 4 Director 17 May 2024, 17:05
RLYB Rallybio Corp 02 Jan 2024 1 +$47,999 4 Director 04 Jan 2024, 17:58
TRDA Entrada Therapeutics, Inc. 08 Jun 2023 1 $0 4 Director, 10%+ Owner 12 Jun 2023, 16:06
RLYB Rallybio Corp 17 May 2023 1 $0 4 Director 19 May 2023, 17:26
RLYB Rallybio Corp 07 Mar 2023 1 -$820,000 4 Director 09 Mar 2023, 15:39
RLYB Rallybio Corp 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 17:29
/report/000110465922124136-parmar-kush-2022-11-30 Akouos, Inc. 30 Nov 2022 3 $0 4 Director, 10%+ Owner 02 Dec 2022, 15:49
/report/000110465922074826-parmar-kush-2022-06-23 Akouos, Inc. 23 Jun 2022 1 $0 4 Director, 10%+ Owner 27 Jun 2022, 17:02
QTTB Homology Medicines, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:05
VOR Vor Biopharma Inc. 14 Jun 2022 1 $0 4 Director, 10%+ Owner 16 Jun 2022, 17:09
RLYB Rallybio Corp 03 Jun 2022 2 -$1,875,000 4 Director, 10%+ Owner 07 Jun 2022, 17:03
TRDA Entrada Therapeutics, Inc. 02 Jun 2022 1 $0 4 Director, 10%+ Owner 06 Jun 2022, 16:01
RLYB Rallybio Corp 24 May 2022 1 $0 4 Director 26 May 2022, 20:08
RLYB Rallybio Corp 23 May 2022 2 -$1,300,000 4 Director, 10%+ Owner 25 May 2022, 18:34
RLYB Rallybio Corp 08 Feb 2022 2 -$2,740,500 4 Director 10 Feb 2022, 17:22
RLYB Rallybio Corp 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 19:38
VOR Vor Biopharma Inc. 16 Nov 2021 2 -$5,059,802 4 Director, 10%+ Owner 18 Nov 2021, 19:10
TRDA Entrada Therapeutics, Inc. 02 Nov 2021 11 +$5,000,000 4 Director, 10%+ Owner 05 Nov 2021, 08:49
TRDA Entrada Therapeutics, Inc. 28 Oct 2021 0 $0 3/A Director, 10%+ Owner 05 Nov 2021, 08:48
TRDA Entrada Therapeutics, Inc. 28 Oct 2021 1 $0 4 Director, 10%+ Owner 01 Nov 2021, 21:48
RLYB Rallybio Corp 29 Jul 2021 0 $0 3 Director, 10%+ Owner 29 Jul 2021, 19:38
RLYB Rallybio Corp 28 Jul 2021 8 +$7,999,992 4 Director 04 Aug 2021, 21:19
/report/000110465921085766-parmar-kush-2021-06-24 Akouos, Inc. 24 Jun 2021 1 $0 4 Director, 10%+ Owner 25 Jun 2021, 16:38
QTTB Homology Medicines, Inc. 17 Jun 2021 1 $0 4 Director 22 Jun 2021, 17:40